Shield Therapeutics

About:

Shield Therapeutics is a pharmaceutical company developing and commercializing late-stage, mineral-derived pharmaceuticals.

Website: http://www.shieldtherapeutics.com

Top Investors: SWK Holdings, Peel Hunt, Inventages Venture Capital Investment Inc., Cavendish Corporate Finance, AOP Global Health

Description:

Shield Therapeutics is an independent specialty pharmaceutical company focused on the development and commercialisation of late-stage, mineral-derived hospital pharmaceuticals which address areas of high unmet medical need. During 2011 Shield will be commencing global pivotal Phase III studies of its lead asset, ST10-021, for the treatment of iron deficiency anaemia associated with inflammatory bowel disease and subsequently chronic kidney disease. The Company is headquartered in Wollerau, Switzerland.